The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute ...

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies ...

Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded by 3.6% YoY to 42.7% ...

There is no cure for congenital erythropoietic porphyria, but after years of work and patient collaboration, a potential drug ...

The global Zoonotic Disease Treatment Market, valued at USD 46.4 billion in 2025, is projected to grow to USD 82.3 billion by ...